Cargando…

Imaging tumour response: beyond RECIST

Detalles Bibliográficos
Autor principal:	Koh, Dow-Mu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242743/ http://dx.doi.org/10.1186/1470-7330-14-S1-O36

Ejemplares similares

Response assessment in daily practice: RECIST and its modifications
por: Sohaib, Aslam
Publicado: (2014)

Cancer imaging in the era of precision treatment: present and future
por: Koh, Dow-Mu
Publicado: (2014)

Imaging biomarkers for evaluating tumor response: RECIST and beyond
por: Ko, Ching-Chung, et al.
Publicado: (2021)

Whole-body DWI in practice
por: Padhani, Anwar, et al.
Publicado: (2014)

Imaging tumour response - challenges
por: Rasmussen, Finn
Publicado: (2015)

Imaging beyond RECIST: CT and MRI in molecular therapies
por: Diederich, Stefan
Publicado: (2012)

Beyond the image : sense and non-sense in imaging biomarkers
por: Oudkerk, Matthijs
Publicado: (2014)

Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
por: Lin, Chien-Ju, et al.
Publicado: (2015)

Role of molecular imaging in the detection of neuroendocrine tumour
por: Wild, Damian
Publicado: (2014)

Theranostics: radionuclide imaging and therapy in neuroendocrine tumours
por: Drake, Brent, et al.
Publicado: (2015)

RECIST criteria: our experience in daily practice
por: De Luca, S, et al.
Publicado: (2015)

Imaging neuroendocrine tumours of the pancreas: role of CT and MRI
por: Sahdev, Anju
Publicado: (2014)

Evaluating tumour response to primary radiochemotherapy in breast cancer patients: what role for breast magnetic resonance imaging?
por: Thibault, F, et al.
Publicado: (2008)

Pediatric tumours: liver tumours
por: Towbin, Alexander J
Publicado: (2014)

Pediatric tumours: pseudotumour or a tumour?
por: Huisman, Thierry AGM
Publicado: (2014)

Chemoprevention: beyond tamoxifen
por: Cuzick, J
Publicado: (2005)

Orbital tumours
por: Chong, Vincent
Publicado: (2015)

RECIST rules
por: Sohaib, Aslam
Publicado: (2012)

Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group – ESOI Joint Paper
por: Fournier, Laure, et al.
Publicado: (2022)

An FDA Pooled Analysis of Patients with Melanoma Treated with an Anti-PD1 Antibody Beyond RECIST Progression
por: Beaver, Julia A., et al.
Publicado: (2018)

Beyond insulin: rethinking cellular metabolism
por: Thompson, Craig B
Publicado: (2012)

Metabolism and metastasis: in the bone marrow and beyond
por: Dias, Sérgio
Publicado: (2010)

The pathology of inherited breast tumours
por: Stratton, M
Publicado: (2000)

Novel roles for integrins in tumour angiogenesis
por: Germain, M, et al.
Publicado: (2006)

Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria
por: Zhou, Meng, et al.
Publicado: (2021)

Targeting HER2 in breast cancer: beyond trastuzumab
por: Winer, EP
Publicado: (2011)

RECIST 1.1 versus mRECIST for assessment of tumour response to molecular targeted therapies and disease outcomes in patients with hepatocellular carcinoma: a systematic review and meta-analysis
por: Yu, Hongli, et al.
Publicado: (2022)

RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline
por: van Persijn van Meerten, Els L., et al.
Publicado: (2009)

Response assessment in metronomic chemotherapy: RECIST or PERCIST?
por: Agrawal, Archi, et al.
Publicado: (2014)

Prioritisation of specialist health care services: going beyond the evidence
por: Webb, Philip, et al.
Publicado: (2014)

Eating disorders in young males: moving beyond stereotype and stigma
por: Shu, Chloe, et al.
Publicado: (2014)

How safe is growth hormone therapy? SAGhE and beyond
por: Carel, Jean-Claude
Publicado: (2013)

Beyond descriptor vectors: QSAR modelling using structural similarity
por: Zell, Andreas, et al.
Publicado: (2008)

Cytomics of the tumour microenvironment: therapeutic targeting (keynote lecture)
por: Smith, Paul
Publicado: (2015)

Investigation of 3-dimensional radiographic imaging as treated with Hyu Spinal corrective technique
por: HoSeong, Kim, et al.
Publicado: (2013)

Tumour-selective transcriptional targeting for breast cancer gene therapy
por: Hurst, HC
Publicado: (2000)

The use of CO2 laser in tumour resection of the oropharyngeal region
por: Jerjes, Waseem, et al.
Publicado: (2010)

Assessment of tumour resection margins using optical coherence tomography
por: Hamdoon, Zaid, et al.
Publicado: (2010)

Targeting the tumour microenvironment: denosumab, a new RANKL inhibitor
por: Coleman, RE
Publicado: (2009)

P276 Molecular epidemiology of clinical filamentous fungi in Qatar beyond Aspergillus and Fusarium
por: Mohamed, Husam Eldin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s3u1qd3meattd23nj3s8f748kk